Today, TIME revealed its annual list of the Best Inventions, which features extraordinary innovations changing our lives. Mirvie’s Encompass was named among the top Medical & Healthcare inventions of 2025.
Encompass provides a first-of-its-kind, personalized risk prediction of preeclampsia early via a simple blood test so pregnant women and their care teams can take action to support a healthy pregnancy and change the tide on increasing preeclampsia rates.
“We are proud and honored that Encompass is recognized as a TIME Best Invention of 2025,” said Maneesh Jain, CEO and co-founder of Mirvie. “For 100 years, the reactive approach to identifying preeclampsia in pregnancy hasn’t changed – until now. At Mirvie, we’ve invented tools that predict pregnancy complications - like preeclampsia - early enough for moms and their care teams to take preventive action. Innovations like Encompass are essential to delivering the next-generation pregnancy care that is needed to improve maternal health outcomes.”
To compile this year's list, TIME solicited nominations from TIME editors and correspondents around the world, and through an online application process, paying special attention to growing fields—such as health care and AI. TIME then evaluated each contender on a number of key factors, including originality, efficacy, ambition, and impact.
See the full list here: https://time.com/collections/best-inventions-2025/7318447/mirvie-encompass/?filters=medical-and-healthcare
Preeclampsia affects 1 in 12 pregnancies and can lead to serious complications. From NICU stays to lasting impacts on you and your baby, preeclampsia can bring unexpected emotional and financial strain. Encompass™ combines a breakthrough blood test to predict personal preeclampsia risk with a preventive action plan and a responsive virtual assistant for individualized support, guiding pregnant women and their care teams towards the healthiest pregnancy possible. Learn more at encompasstest.com/get-the-test
Mirvie is bringing scientifically rigorous and data-driven approaches to solving some of the most pressing clinical problems in women’s health, beginning with pregnancy. Serious complications impact one in five pregnancies in the U.S., and Mirvie is committed to creating a world where every pregnancy is as safe and healthy as possible. Founded and led by a team of seasoned entrepreneurs and scientists, the company is based in South San Francisco, California and backed by top-tier investors including Blackrock, Decheng Capital, Foresite Capital, General Catalyst, GV, Khosla Ventures, and Mayfield. For more information, visit Mirvie.com.
Kate Enos
Director of Media Relations
kate@mirvie.com
